prescription medicine registration process performance · 2016-08-17 · prescription medicine...

30
Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt Business Review and Reporting Section Prescription Medicines Authorisation Branch Medicines Regulation Division, TGA ARCS Scientific Congress Canberra 2016 11 August 2016

Upload: others

Post on 27-Jun-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Prescription medicine registration process performance The milestone-based process 2010 - 2016

Dr Paul Huleatt Business Review and Reporting Section Prescription Medicines Authorisation Branch Medicines Regulation Division, TGA ARCS Scientific Congress Canberra 2016

11 August 2016

Page 2: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Overview The prescription medicine registration process

• Background

• Process Performance Part 1: Timeliness and Predictability

• Process Performance Part 2: Milestone Analysis

• Process Support: Case management and Enabling Tools

• New initiatives: A simplified pre-submission phase

1

Page 3: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Background The prescription medicine registration process • In 2010 the TGA, in consultation with industry introduced a series of Business Process Reforms (BPR)

that aimed to introduce predictability and improve the timeliness of the registration of prescription medicines.

• A commitment was also made to increase the transparency of the TGA’s internal practices and to

enhance communication with applicants.

• The ‘Streamlined Submission Process’ for prescription medicine category 1 and 2 submissions was introduced.

• This milestone-based process consisting of eight phases with eight milestones is intended to allow

effective planning and tracking of submissions by the TGA and applicants. • The process is underpinned by business rules, mandatory requirements and legislated timeframes.

2

Page 4: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Background Volume of Submissions by Quarter (Nov-2010 to Jun-2016)

0

20

40

60

80

100

120

140

Total

A

B

C

D

FJ

Since the July 2014 batch 775 PPFs submitted 95 Type A (12.3%) 13 Type B (1.7%) 97 Type C (12.5%) 297 Type D (38.3%) 96 Type F (12.4%) 162 Type J (20.9%) 15 Type G or H (1.9%)

3

Page 5: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Background Relative Submission Volumes

1100

1150

1200

1250

1300

1350

Subm

issi

ons o

n H

and

-80

-60

-40

-20

0

20

40

60

Net

Sub

mis

sion

s In/

Out

-80

-60

-40

-20

0

20

40

60

Net

Sub

mis

sion

s In/

Out

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

0

100

200

300

400

500

600

700

800

900

Category 1 Other

Subm

issi

ons o

n H

and

Page 6: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Streamlined submission process From inception until June 2013

MS2 MS3 MS1 MS4 MS5 MS7 MS8 ACPM

Delegate’s Overview

4-5 months ~ 2-3 months 3 weeks 1 month

MS6

Page 7: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Streamlined submission process All Category 1 Submissions except new generic medicines - July 2013 batch onwards

MS2 MS3 MS1 MS4 MS5 MS7 MS8 ACPM

Delegate’s Overview

5 months 6 weeks 6 weeks ~ 2-3 months

MS6

Page 8: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Streamlined submission process New generic medicines workflow - July 2013 batch onwards

MS2 MS3 MS1 MS4 MS5 MS7 MS8

4 months 6 weeks 6 weeks 2 months

Page 9: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Overview The prescription medicine registration process

• Background

• Process Performance Part 1: Timeliness and Predictability

• Process Performance Part 2: Milestone Analysis

• Process Support: Case management and Enabling Tools

• New initiatives: A simplified pre-submission phase

8

Page 10: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Benchmarking performance – Type A submissions Approval times shown in calendar days

Time from ‘effective’ to ‘decision’

Analysis Performed Registration Process

Number of Type A

Submissions Approved

Average Median Minimum Maximum

May 2015 Pre-BPR (from 2004-2010) 207 434 427 119 968

Cohort 1 (Pre-business rule changes)

60 360 353 270 567

June 2016 Cohort 2 (Post-business rule changes)

68 360 346.5 166 713

Reduction in average approval time of over 2 months

These times do not take into account the three month pre-submission and submission phases of the current process or the 40 working day screening phase of the previous process.

9

Page 11: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Benchmarking performance – Type A Submissions Stop Clocks

Pre-BPR (2004-2010) An average of 7 clock stops per NCE submission were applied. Combined SSP Cohorts (Type A Submissions) Of the 128 submissions: - 103 were processed with the single, planned stop clock phase (80%) - 17 submissions experienced an additional Mutual Stop the Clock (i.e. a total of 2 stop clock events) - 5 submissions were processed with two Mutual Stop the Clocks (i.e. a total of 3 stop clock events) - 3 submissions were processed with three Mutual Stop the Clocks (i.e. a total of 4 stop clock events)

10

Page 12: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Benchmarking performance – Extensions of indications Approval times shown in calendar days

Time from ‘effective’ to ‘decision’

Analysis Performed Registration Process

Number of Type C

Submissions Approved

Average Median Minimum Maximum

June 2016 Cohort 1 (post business rule changes)

73 331 334 187 510

Average approval time around 1 month less than for Type A submissions

These times do not take into account the three month pre-submission and submission phases of the current process.

11

Page 13: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Benchmarking performance – New generic medicines Time from ‘effective’ to ‘decision’

Analysis Performed Registration Process

Number of Type D

Submissions Approved

Average Median Minimum Maximum

June 2015 Pre-BPR 145 428 432 61 891

June 2016 Cohort 1 (Pre-business rule changes)

82 316 317 196 608

June 2015 Cohort 2 (Post-business rule changes)

77 297 293 210 394

February 2016 Cohort 3 74 352 301.5 217 874

June 2016 Cohort 4 60 348 291 226 802

Approval times shown in calendar days

Reduction in average approval time of over 2 months. These times do not take into account the three month pre-submission and submission phases of the current process or the 40 working day screening phase of the previous process.

12

Page 14: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Benchmarking performance – New generic medicines Timeframe: acceptance of the dossier for evaluation until decision

• Pre-BPR (145 submissions)

– 20% took longer than 500 calendar days – 66% took longer than 400 calendar days – 91% took longer than 300 calendar days – Average of 3 stop clock events

• Combined SSP cohorts (293 submissions)

– 6% took longer than 500 calendar days – 12% took longer than 400 calendar days – 54% took longer than 300 calendar days 13

Page 15: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Overview The prescription medicine registration process

• Background

• Process Performance Part 1: Timeliness and Predictability

• Process Performance Part 2: Milestone Analysis

• Process Support: Case management and Enabling Tools

• New initiatives: A simplified pre-submission phase

14

Page 16: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Methodology

• Planned dates were taken from the Notification Letter issued at Milestone 2.

• Actual dates were taken from the letter sent to applicant (last correspondence on record for that Milestone).

• The difference between ‘planned’ and ‘actual’ dates was determined in calendar days.

• All of the submissions included in this analysis were approved within the legislated 255 working days.

15

Page 17: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Analysis of performance – Type A submissions

• No notable delays were recorded at Milestones 1 and 2.

• The ACPM meeting outcomes comprise Milestone 6 and are based on the relevant ratified ACPM calendar dates. This Milestone is met with respect to the Delegate’s Overview.

• Focus on Milestones 3, 5, 7, 8 and the planned ACPM meeting.

Page 18: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Type A Submissions

Milestone 3 Milestone 5 ACPM Milestone 7 Milestone 8

Cohort 1

Cohort 2

Not sent to ACPM

Moved to earlier meeting

Met planned meeting

Mutually agreed deferral

Deferred due to delays

On time and early

Day after public holiday/weekend

Within 1 week

1-2 weeks

More than 2 weeks

On time and early

Day after public holiday/weekend

Within 1 week

1-2 weeks

More than 2 weeks

Page 19: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Comparative performance – Type A submissions Pre- and post-business rule changes

• Overall predictability of the approval date (Milestone 7) has improved.

• Delays experienced at end of evaluation rounds (Milestones 3 and 5).

• Delays at Milestone 5 reflect provision of final evaluation reports with the Delegate’s overview

• ACPM target met for 86% of submissions.

• Planned registration date now being met for >80% of submissions. 18

Page 20: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Analysis of performance – Type A submissions Difference between actual and planned dates

The reasons for these differences were sought and the following factors were identified:

• Applicant submits additional information (which may require a mutual stop clock)

• TGA requests additional data requiring evaluation (which may require a mutual stop clock)

• Post-ACPM negotiation (involving, for example, the PI or RMP)

19

Page 21: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Analysis of performance – New generic medicines

Time from ‘effective’ to ‘decision’

Registration Process Number of Type D Submissions

Approved Average Median Minimum Maximum

Cohort 1 (Pre-business rule changes)

82

316 317 196 608

Cohort 2 (Post-business rule changes)

77 297 293 210 394

Cohort 3 74 352 301.5 217 874

Cohort 4 60 348 291 226 802

• No notable delays were recorded at Milestones 1 and 2 for the generic medicines analysed. • Focus on Milestones 3, 5, 7 and 8.

20

Page 22: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

New Generic Medicines

On time and early

Day after public holiday /weekend

Within 1 week

1-2 weeks

More than 2 weeks

Milestone 3 Milestone 5 Milestone 7 Milestone 8

Cohort 1

Pre-business rule changes

Cohort 2

Post-business rule changes

Cohort 3

Cohort 4 21

Page 23: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Analysis of Performance – New generic medicines Combined cohort analysis – 293 submissions

• <10% of submissions were on time or early at every milestone

• 49% of submissions were on time or early at Milestone 3

– Pre-business rule changes: 75% of submissions on time at Milestone 3 were also on time at Milestone 7 – Post-business rule changes: 49% of submissions on time at Milestone 3 were also on time at Milestone 7

• 43% of submissions were on time or early at Milestone 7

– 88% of those submissions were subsequently on time or early at Milestone 8 – 10% of those submissions were subsequently late at Milestone 8 and the average delay was 134 days.

22

Page 24: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Overview The prescription medicine registration process

• Background

• Process Performance Part 1: Timeliness and Predictability

• Process Performance Part 2: Milestone Analysis

• New initiatives: A simplified pre-submission phase

• Process Support: Case management and Enabling Tools

23

Page 26: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Overview The prescription medicine registration process

• Background

• Process Performance Part 1: Timeliness and Predictability

• Process Performance Part 2: Milestone Analysis

• Process Support: Case management and Enabling Tools

• New initiatives: A simplified pre-submission phase

25

Page 27: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Pre-submission Pilot - Overview • From 1 Feb 2016 until 30 September 2016

• No ‘Module 2 or equivalent’ provided with Pre-submission Planning Form

• Reduced processing time (single filter)

• No Milestone 1 planning letter

• Standard business rules apply once dossier is accepted for evaluation

• Eligible applications:

NCEs or New Generic Medicines with Version 3.0 eCTD dossier (AU specification) 26

Page 28: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Pre-submission Pilot vs standard process Comparative submission timelines

PPF lodgement PPF Filter Dossier Filter

Month 1 Month 2 Month 3 Month 4 Month 5

Milestone 1 Milestone 2

Dossier lodgement Evaluation

Dossier lodgement Dossier Filter

Milestone 2

PPF lodgement

15th of month

Standard Process

Pilot Process

Evaluation

Page 29: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt

Summary The prescription medicine registration process

• Background

• Process Performance Part 1: Timeliness and Predictability - Significantly improved

• Process Performance Part 2: Milestone Analysis - Clear areas for future focus

• Process Support: Case management and Enabling Tools - Key to all stakeholders

• New initiatives: A simplified pre-submission phase - Continual process improvement

28

Page 30: Prescription medicine registration process performance · 2016-08-17 · Prescription medicine registration process performance The milestone-based process 2010 - 2016 Dr Paul Huleatt